10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 272 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,155 | -62.0% | 28 | -50.0% | 0.00% | – |
| Q2 2023 | $3,041 | +105.9% | 56 | +100.0% | 0.00% | – |
| Q1 2023 | $1,477 | +36825.0% | 28 | -62.2% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 74 | -56.7% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 171 | +1.2% | 0.00% | – |
| Q2 2022 | $14,000 | -22.2% | 169 | -23.9% | 0.00% | – |
| Q1 2022 | $18,000 | +260.0% | 222 | +534.3% | 0.00% | – |
| Q4 2021 | $5,000 | +25.0% | 35 | +25.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 28 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | – | 28 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 10 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2019 | $47,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |